Characterization of a novel ADAM protease expressed by Pneumocystis carinii

Cassie C Kennedy1, Theodore J Kottom, Andrew H Limper

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Insights

This study identifies a novel protease, Pneumocystis carinii ADAM (PcADAM), in the opportunistic fungus Pneumocystis. This protease is active and its expression increases during the fungal cyst stage.

Area of Science:

  • Mycology
  • Molecular Biology
  • Medical Mycology

Background:

  • Pneumocystis species are opportunistic fungal pathogens causing pneumonia in immunocompromised individuals.
  • Unidentified proteases are suspected to regulate the Pneumocystis life cycle.
  • ADAM (a disintegrin and metalloprotease) family molecules are known regulators in other fungi.

Purpose of the Study:

  • To characterize ADAM-like molecules in Pneumocystis carinii (PcADAM).
  • To investigate the role of PcADAM in the Pneumocystis life cycle.

Main Methods:

  • In silico search and PCR extension cloning to obtain the full-length PcADAM gene.
  • Northern blot to analyze PcADAM expression during the Pneumocystis life cycle.
  • Heterologous expression in Saccharomyces cerevisiae and casein zymography to assess protease activity.

Main Results:

  • A full-length PcADAM gene (1,650 bp) with a conserved ADAM catalytic active site was identified.
  • PcADAM expression was higher in Pneumocystis cysts than in trophic forms.
  • Purified PcADAMp demonstrated zinc-dependent proteolytic activity, confirmed in native Pneumocystis extracts.

Conclusions:

  • This is the first report of a specific, characterized protein with protease activity in Pneumocystis.
  • PcADAM is likely involved in the regulation of the Pneumocystis life cycle, particularly during the cyst stage.